These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2494735)

  • 1. The effects of ionizing radiation and dexamethasone on the blood-brain-barrier and blood-tumor-barrier: implications for boron neutron capture therapy of brain tumors.
    Dorn RV; Spickard JH; Griebenow ML
    Strahlenther Onkol; 1989; 165(2-3):219-21. PubMed ID: 2494735
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose bracketing in boron neutron capture therapy.
    Gahbauer R; Kanellitsas C; Blue T; Wang C; Clendenon N; Fairchild R; Laster B; McGregor J; Goodman J
    Strahlenther Onkol; 1989; 165(2-3):229-30. PubMed ID: 2494738
    [No Abstract]   [Full Text] [Related]  

  • 3. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multidisciplinary program leading to a clinical trial of neutron capture therapy at Tufts-New England Medical Center and the Massachusetts Institute of Technology.
    Zamenhof RG; Madoc-Jones H; Harling OK; Bernard JA
    Strahlenther Onkol; 1989; 165(2-3):254-7. PubMed ID: 2538941
    [No Abstract]   [Full Text] [Related]  

  • 5. Computerized axial tomographic and magnetic resonance imaging scan follow-up of two patients after boron neutron capture therapy for glioblastoma multiforme.
    Marano SR; Spickard JH; Griebenow ML
    Strahlenther Onkol; 1989; 165(2-3):240-2. PubMed ID: 2538940
    [No Abstract]   [Full Text] [Related]  

  • 6. Monte Carlo treatment planning and high-resolution alpha-track autoradiography for neutron capture therapy.
    Zamenhof RG; Clement S; Lin K; Lui C; Ziegelmiller D; Harling OK
    Strahlenther Onkol; 1989; 165(2-3):188-92. PubMed ID: 2494725
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Boron-10-slow neutron capture therapy for brain tumors (author's transl)].
    Hatanaka H; Amano K; Sano K; Mogami H; Hayakawa T
    No Shinkei Geka; 1974 Jan; 2(1):7-16. PubMed ID: 4372576
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy.
    Mill AJ
    Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726
    [No Abstract]   [Full Text] [Related]  

  • 10. Head phantom experiment and calculation for NCT using various neutron beams.
    Matsumoto T; Aizawa O
    Strahlenther Onkol; 1989; 165(2-3):98-100. PubMed ID: 2494756
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of ionizing radiation on the blood-brain-barrier (BBB): considerations for the application of boron neutron capture therapy (BNCT) of brain tumors.
    Dorn RV; Spickard JH; Griebenow ML
    Basic Life Sci; 1989; 50():145-52. PubMed ID: 2751605
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
    Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
    Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method of in situ dosimetry in boron neutron capture therapy.
    Blue J; Roberts W; Blue T; Wang C
    Strahlenther Onkol; 1989; 165(2-3):109-12. PubMed ID: 2494710
    [No Abstract]   [Full Text] [Related]  

  • 14. Fractionation and other clinical considerations in boron neutron capture therapy.
    Durrant KR; Hopewell JW
    Strahlenther Onkol; 1989; 165(2-3):231-3. PubMed ID: 2494739
    [No Abstract]   [Full Text] [Related]  

  • 15. Canine spontaneous brain tumors--a large animal model for BNCT.
    Gavin PR; Kraft SL; Wendling LR; Miller DL
    Strahlenther Onkol; 1989; 165(2-3):225-8. PubMed ID: 2494737
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
    van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
    Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three cases of terminal stage malignant gliomas in which the diffusely disseminated intraventricular tumors became the target of boron neutron capture therapy.
    Montagno Ede A; Moreira Filho L; Hatanaka H
    Strahlenther Onkol; 1989; 165(2-3):238-40. PubMed ID: 2494740
    [No Abstract]   [Full Text] [Related]  

  • 18. A design study of an accelerator-based epithermal neutron source for boron neutron capture therapy.
    Wang CK; Blue TE; Gahbauer RA
    Strahlenther Onkol; 1989; 165(2-3):75-8. PubMed ID: 2494748
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview: radiation sources, beam quality, dosimetry and spectroscopy in neutron capture therapy.
    Kanda K
    Strahlenther Onkol; 1989; 165(2-3):67-9. PubMed ID: 2494745
    [No Abstract]   [Full Text] [Related]  

  • 20. A proposed protocol for clinical trials of boron neutron capture therapy in glioblastoma multiforme.
    Dorn RV; Spickard JH; Griebenow ML
    Strahlenther Onkol; 1989; 165(2-3):233-4. PubMed ID: 2538939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.